• No#766, Tongcheng Road
    Kunshan, Jiangsu Province,China

  • 86-21-2024 2659

  • Get A Quote

        Search:        

Building Block banner
  • Building Block

    Welcome to PHARMACORE CO.,LIMITED

    　　
    PharmaCore provides custom synthesis and contract research of both catalog and non-catalog building blocks.
     
    With high quality and competitive price.
     
    Offering you the first-rate service and high-efficiency business.
     
    Air freight service: door to door services.

  • (S)-pyrrolidine-3-carboxylic acid

    201322845(S)-pyrrolidine-3-carboxylic acid

  • pyrrolidine-3-carboxylic acid hydrochloride

    201322846pyrrolidine-3-carboxylic acid hydrochloride

  • (R)-pyrrolidine-3-carboxylic acid hydrochloride

    201322847(R)-pyrrolidine-3-carboxylic acid hydrochloride

  • (S)-pyrrolidine-3-carboxylic acid hydrochloride

    201322848(S)-pyrrolidine-3-carboxylic acid hydrochloride

  • (R)-methyl pyrrolidine-3-carboxylate hydrochloride

    201322849(R)-methyl pyrrolidine-3-carboxylate hydrochloride

  • (S)-methyl pyrrolidine-3-carboxylate hydrochloride

    201322850(S)-methyl pyrrolidine-3-carboxylate hydrochloride

  • ethyl pyrrolidine-3-carboxylate hydrochloride

    201322851ethyl pyrrolidine-3-carboxylate hydrochloride

  • (R)-ethyl pyrrolidine-3-carboxylate

    201322852(R)-ethyl pyrrolidine-3-carboxylate

  • (S)-ethyl pyrrolidine-3-carboxylate hydrochloride

    201322853(S)-ethyl pyrrolidine-3-carboxylate hydrochloride

  • (S)-ethyl pyrrolidine-3-carboxylate

    201322854(S)-ethyl pyrrolidine-3-carboxylate

  • tert-Butyl(pyrrolidin-3-ylmethyl)carbamate

    201322855tert-Butyl(pyrrolidin-3-ylmethyl)carbamate

  • (S)-tert-Butyl(pyrrolidin-3-ylmethyl)carbamate

    201322856(S)-tert-Butyl(pyrrolidin-3-ylmethyl)carbamate

First Previous Page 3804 3805 3806 3807 3808 3809 3810 3811 3812 3813 3814 Next Page Last Page Total 4598Page55170 Record

Copyright @ PHARMACORE CO.,LIMITED. Our products are listed related to patents, for research purposes only, no commercial sales.

Back to the top